BioNTech co-founder Ozlem Tureci says Covid will be with us for many years

Read Time:3 Minute, 7 Second


London-Co-founder and Chief Medical Officer Biological Technology, This German company also developed a Covid-19 vaccine Pfizer, Told CNBC that the world “should not live in fear of viruses.”

“Covid will become controllable. It has begun to become controllable,” Dr. Ozlem Tureci said in the latest episode of “CNBC Dialogue.”

However, she added that we will “need to return to a new normal, because this virus will still be with us for several years.”

When asked about her concerns about the new coronavirus variants, she said that BioNTech “continuously evaluates the upcoming variants, and there will be more.”

“For all these variants currently in fashion, it seems that the use of boosters alone to restore the weakened immune response to a high level is appropriate and does have a protective effect,” she said.

“However, we must continue to screen because there may be variants that are about to emerge, but this is not the case. For this, we have a second pillar, that is, we are ready to get to a variant quickly and quickly if we need to adapt.. …. We are conducting these trial runs with regulators, not individually, so that they are also prepared for potential conversion needs,” Tureck told CNBC.

Tureci co-founded Germany-based BioNTech in 2008 with her husband and CEO Ugur Sahin. She said that more data is needed to guide the escape from the pandemic, but she can imagine that future boosters can be given “every 12 months or every 18 months.”

The new crown vaccine in less than a year

The company’s main focus is to “create personalized immunotherapy” for cancer drugs and use its mRNA (messenger ribonucleic acid) technology to stimulate the body’s own immune response. It is also committed to the development of a malaria vaccine.

“So we already have the science and knowledge about immune mechanisms and how they can be used to fight the virus and can use it,” Tureck said.

“The other pillar we are dealing with is our technology, which is mRNA technology, which allows [it] Used as a vaccine form, which means it allows [it] Communicate with the immune system and teach it how to deal with this new enemy with high precision. ”

“And this technology, because we have used it in clinical trials for cancer patients, has matured. We know how to use it for clinical trials, how to use it to treat humans, and how to build a manufacturing process,” she added. .

Learn a lesson

The company’s experience means it can develop a vaccine in less than a year.

When asked whether this is also the case for all other vaccines in the future, Turec told CNBC that “response to this global threat requires great attention,” but lessons can be learned and advanced.

“I think there are a few things that can help us faster if we transfer them to future drug development. In addition, for example, for non-pandemic infections, there are cancers and autoimmune diseases,” she said .

Natural gender balance

Since the Oxford-AstraZeneca Covid vaccine is also led by female scientists, Tureck believes that such a striking example of gender balance in science is “very important” and is one of the reasons behind BioNTech’s success.

“Actually, I really believe that one of the secrets of our success as a team and a company is that we are a gender-balanced team. Almost half of our employees are women, and among the top management, half of us are Women. The team is women,” she said.

“However, I also realize that in our team, we don’t recruit women because we want to complete any gender quota, which is natural…it turns out that half of them are women,” she continued.

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %
We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We also share information about your use of our site with our social media, advertising and analytics partners. View more
Cookies settings
Accept
Decline
Privacy & Cookie policy
Privacy & Cookies policy
Cookie name Active

Who we are

Suggested text: Our website address is: https://updatednews24.com.

Comments

Suggested text: When visitors leave comments on the site we collect the data shown in the comments form, and also the visitor’s IP address and browser user agent string to help spam detection. An anonymized string created from your email address (also called a hash) may be provided to the Gravatar service to see if you are using it. The Gravatar service privacy policy is available here: https://automattic.com/privacy/. After approval of your comment, your profile picture is visible to the public in the context of your comment.

Media

Suggested text: If you upload images to the website, you should avoid uploading images with embedded location data (EXIF GPS) included. Visitors to the website can download and extract any location data from images on the website.

Cookies

Suggested text: If you leave a comment on our site you may opt-in to saving your name, email address and website in cookies. These are for your convenience so that you do not have to fill in your details again when you leave another comment. These cookies will last for one year. If you visit our login page, we will set a temporary cookie to determine if your browser accepts cookies. This cookie contains no personal data and is discarded when you close your browser. When you log in, we will also set up several cookies to save your login information and your screen display choices. Login cookies last for two days, and screen options cookies last for a year. If you select "Remember Me", your login will persist for two weeks. If you log out of your account, the login cookies will be removed. If you edit or publish an article, an additional cookie will be saved in your browser. This cookie includes no personal data and simply indicates the post ID of the article you just edited. It expires after 1 day.

Embedded content from other websites

Suggested text: Articles on this site may include embedded content (e.g. videos, images, articles, etc.). Embedded content from other websites behaves in the exact same way as if the visitor has visited the other website. These websites may collect data about you, use cookies, embed additional third-party tracking, and monitor your interaction with that embedded content, including tracking your interaction with the embedded content if you have an account and are logged in to that website.

Who we share your data with

Suggested text: If you request a password reset, your IP address will be included in the reset email.

How long we retain your data

Suggested text: If you leave a comment, the comment and its metadata are retained indefinitely. This is so we can recognize and approve any follow-up comments automatically instead of holding them in a moderation queue. For users that register on our website (if any), we also store the personal information they provide in their user profile. All users can see, edit, or delete their personal information at any time (except they cannot change their username). Website administrators can also see and edit that information.

What rights you have over your data

Suggested text: If you have an account on this site, or have left comments, you can request to receive an exported file of the personal data we hold about you, including any data you have provided to us. You can also request that we erase any personal data we hold about you. This does not include any data we are obliged to keep for administrative, legal, or security purposes.

Where we send your data

Suggested text: Visitor comments may be checked through an automated spam detection service.
Save settings
Cookies settings